Related Experiment Video

Updated: Aug 5, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Pediatric clinical research

Daniel J Lovell1, Natasha M Ruth

  • 1Cincinnati Children's Hospital, Cincinnati, Ohio 45229, USA. Daniel.lovell@cchmc.org

Current Opinion in Rheumatology
|April 20, 2005
PubMed

Insights

This review covers advancements in diagnosing and treating childhood-onset systemic lupus erythematosus, juvenile idiopathic arthritis, and juvenile dermatomyositis, focusing on improving quality of life for affected children.

Area of Science:

  • Pediatric Rheumatology
  • Autoimmune Diseases in Children
  • Inflammatory Conditions

Background:

  • Childhood-onset systemic lupus erythematosus (cSLE), juvenile idiopathic arthritis (JIA), and juvenile dermatomyositis (JDM) are significant pediatric rheumatic diseases.
  • These conditions impact children's health-related quality of life (HRQoL).
  • Understanding disease mechanisms and treatment responses is crucial for effective management.

Purpose of the Study:

  • To review recent progress in the diagnosis and treatment of cSLE, JIA, and JDM.
  • To highlight strategies aimed at enhancing HRQoL in pediatric rheumatic diseases.
  • To synthesize key findings on disease activity markers and therapeutic interventions.

Main Methods:

  • Literature review of recent studies on cSLE, JIA, and JDM.
  • Analysis of diagnostic markers and imaging techniques.
  • Evaluation of treatment outcomes, including medication efficacy and novel therapies.

Main Results:

  • Atherosclerosis risk factors in cSLE include insulin, lipoproteins, and oxidized markers.
  • Myeloid-related proteins (S100A8/A9) and S100A12 indicate disease activity in JIA.
  • MRI and CT reveal cartilage changes and bone geometry issues in JIA.
  • Subcutaneous methotrexate is effective for methotrexate-resistant JIA.
  • Synovial inflammation influences relapse in JIA.
  • Quantitative MRI and MHC Class I expression are noted in early JDM.
  • Intravenous cyclophosphamide and tacrolimus ointment show promise for refractory JDM.

Conclusions:

  • Significant advancements have been achieved in the diagnosis and treatment of cSLE, JIA, and JDM.
  • Ongoing research continues to refine management strategies for these pediatric autoimmune conditions.
  • Improving HRQoL remains a key objective in the care of children with these diseases.
Abstract

More Related Videos

Eye Tracking Young Children with Autism09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Related Concept Videos

Case Studies01:22

Case Studies

There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...